Evidence map›Paper›PMID 42898685›Full record

ArticleAddiction & health2026

A Retrospective Cross-Sectional Study on Methadone Poisoning: A Decade of Insights from Kerman, Iran.

Motahareh Soltani, Mohammad Mahdi Ghanbari, Somayyeh Karami-Mohajeri, Zohreh Oghabian, Mohammed Mahdi-Abdulameer, Maryam Dalili, Soudeh Khanamani Falahati-Pour

Abstract read
In one paragraph

Article in Addiction & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Motahareh SoltaniPistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.ORCID https://orcid.org/0000-0001-9974-4007
Mohammad Mahdi GhanbariPharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Somayyeh Karami-MohajeriMedicine and Religious Research Center, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0001-6256-6550
Zohreh OghabianGastroenterology and Hepatology Research Center, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0001-7269-4919
Mohammed Mahdi-AbdulameerIraqi syndicate of pharmacists, Baghdad, Iraq.ORCID https://orcid.org/0009-0005-5318-6595
Maryam DaliliDepartment of Obstetrics and Gynecology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.ORCID https://orcid.org/0000-0003-1550-6031
Soudeh Khanamani Falahati-PourPistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.ORCID https://orcid.org/0000-0002-3539-8982

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methadone poisoning, involving both syrup and tablet formulations, represents a significant public health concern, particularly in regions where methadone is widely utilized for opioid substitution therapy. Methadone accounted for approximately 16% of pediatric acute poisonings and was the leading cause of drug-related deaths in 2023. This study provides a decade-long retrospective analysis of methadone poisoning cases in Kerman, Iran, with a focus on demographic patterns, clinical outcomes, and risk factors to guide prevention and treatment strategies. Methods: This retrospective cross-sectional study reviewed medical records of 5,826 methadone poisoning cases, primarily acute but including some chronic cases, admitted to Afzalipour Hospital between 2013 and 2023. Data on demographics, clinical presentations, comorbidities, and outcomes were analyzed using SPSS version 22, with statistical significance set at Results: The majority of patients were male (63.5%), with the highest prevalence among individuals aged 19-40 years (45.3%). Notably, 17.7% of cases involved children under six years old, primarily due to accidental ingestion linked to unsafe storage practices. Intentional poisoning accounted for 80.2% of cases, underscoring the role of mental health and socio-economic factors. Co-intoxication with benzodiazepines (9.8%) and alcohol (4.9%) exacerbated toxicity, while 8.8% of cases coincided with COVID-19 infection, compounding respiratory complications. The mortality rate was low at 1.9% (95% CI: 1.6-2.2%), with 63.8% of cases achieving full recovery; and notably, 17.7% of cases involved were children aged under six years old. Conclusion: The findings, including high co-intoxication risks with benzodiazepines (9.8%) and alcohol (4.9%), highlight the urgent need for targeted interventions, including stricter regulation of methadone distribution, childproof packaging, and public education campaigns to reduce accidental pediatric poisonings. Integrated mental health services are critical to addressing intentional poisoning cases (80.2%), while healthcare providers should remain vigilant about polysubstance use. These strategies can significantly reduce methadone-related morbidity and mortality, especially among vulnerable populations such as children and young adults.

Indexed as

ChildMethadoneOpiate substitution treatmentPoisoning

Identifiers

PMID42898685
PMCPMC13678043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.